{
    "status": "ok",
    "totalResults": 101,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "ARLnow"
            },
            "author": "Michele Fleming",
            "title": "Double your impact for kids with cancer, September 10\u201314 only",
            "description": "Donate Now to Help Fund Safer, More Effective Treatments for Childhood Cancer At Nathan's Cancer Slayers, a local fundraising team under Alex\u2019s Lemonade Stand Foundation, we are on a mission to change the future for children with rhabdomyosarcoma (RMS) and al\u2026",
            "url": "https://www.arlnow.com/2025/09/10/double-your-impact-for-kids-with-cancer-september-10-14-only-nat8/",
            "urlToImage": "https://www.arlnow.com/wp-content/uploads/2025/09/unnamed-16-1.jpg",
            "publishedAt": "2025-09-10T14:45:42Z",
            "content": "Donate Now to Help Fund Safer, More Effective Treatments for Childhood Cancer\r\nAt Nathan\u2019s Cancer Slayers, a local fundraising team under Alexs Lemonade Stand Foundation, we are on a mission to chang\u2026 [+5529 chars]"
        },
        {
            "source": {
                "id": "the-times-of-india",
                "name": "The Times of India"
            },
            "author": "Nishtha Awasthi",
            "title": "Sun Pharma shares in focus after USFDA flags \u2018official action indicated\u2019 status for Halol facility",
            "description": "Sun Pharma shares: The company revealed that the FDA classified its Halol facility as \u201cOfficial Action Indicated\u201d after finding CGMP violations during a June inspection, resulting in an Import Alert that blocks U.S. shipments except for approved exemptions.",
            "url": "https://economictimes.indiatimes.com/markets/stocks/news/sun-pharma-shares-in-focus-after-usfda-flags-official-action-indicated-status-for-halol-facility/articleshow/123798933.cms",
            "urlToImage": "https://img.etimg.com/thumb/msid-123798925,width-1200,height-630,imgsize-857635,overlay-etmarkets/articleshow.jpg",
            "publishedAt": "2025-09-10T03:35:44Z",
            "content": "Shares of Sun Pharmaceutical Industries will be in focus on Wednesday, September 10, after the company disclosed that the U.S. Food and Drug Administration (FDA) has classified its Halol manufacturin\u2026 [+2183 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "Reuters",
            "title": "Benchmark indices to open higher amid US trade talk hopes, rate cut bets",
            "description": "Nifty 50 has gained about 1.2% in the last five sessions, and is trading about 5.4% below the record high hit on September 27, 2024",
            "url": "https://www.thehindubusinessline.com/markets/benchmark-indices-to-open-higher-amid-us-trade-talk-hopes-rate-cut-bets/article70032364.ece",
            "urlToImage": "https://bl-i.thgim.com/public/incoming/6fd9to/article69954637.ece/alternates/LANDSCAPE_1200/PTI08_07_2025_000283B.jpg",
            "publishedAt": "2025-09-10T02:57:48Z",
            "content": "The equity benchmarks are set to open higher on Wednesday, extending their multi-session winning run fuelled by recent tax cuts, while rising bets for US rate cuts and hopes of progress in trade talk\u2026 [+2128 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "KS Badri Narayanan",
            "title": "Why these 16 stocks will remain in focus in today\u2019s trade (September 10, 2025)",
            "description": "Bikaji Foods, Sun Pharma, Sterling & Wilson,\u00a0Vodafone, Voltamp Transformers, Embassy REIT, NBCC, HEG, LTI Mindtree, Mamata Machinery, Nila Infra, Blue Jet, Samvardhana Motherson, Thermax",
            "url": "https://www.thehindubusinessline.com/markets/why-these-16-stocks-will-remain-in-focus-in-todays-trade-september-10-2025/article70032329.ece",
            "urlToImage": "https://bl-i.thgim.com/public/incoming/3xxesy/article70028487.ece/alternates/LANDSCAPE_1200/PO13_BS_stock_market.jpg",
            "publishedAt": "2025-09-10T02:19:22Z",
            "content": "The Enforcement Directorate has summoned the Bikaji Foods Managing Director in connection with the investigation into the Rajasthan Premier League. Bikaji Foods International, in a regulatory filing \u2026 [+5268 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Vulture"
            },
            "author": "Tom Smyth",
            "title": "Only Murders in the Building Recap: Bodies, Bodies, Bodies",
            "description": "Mabel gets an unwelcome visit from her past in her old pal Althea, played by Beanie Feldstein. At least the underground casino is providing plenty of leads.",
            "url": "http://www.vulture.com/article/only-murders-in-the-building-recap-season-5-episode-3-rigor.html",
            "urlToImage": "https://pyxis.nymag.com/v1/imgs/547/b21/d51ec797c0355a706e2b9a0bc8d01deaab-onlymurders-s5-5.1x.rsocial.w1200.jpg",
            "publishedAt": "2025-09-09T18:00:10Z",
            "content": "In case you havent learned to suspend your disbelief by now and are in search of an explanation about where the secret casino under the Arconia came from, Ive got good news for you. The episode opens\u2026 [+6419 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Observer"
            },
            "author": "Siddhant Adlakha, Siddhant Adlakha",
            "title": "Screening at Venice: Yorgos Lanthimos\u2019 \u2018Bugonia\u2019",
            "description": "The filmmaker has reimagined a cult classic for an era defined by online conspiracies and unchecked digital influence.",
            "url": "https://observer.com/2025/09/movie-review-yorgos-lanthimos-bugonia-venice-film-festival/",
            "urlToImage": "https://observer.com/wp-content/uploads/sites/2/2025/09/4243_D019_00087.jpg?quality=80",
            "publishedAt": "2025-09-09T17:12:09Z",
            "content": "Emma Stone as Michelle. Atsushi Nishijima/Focus Features \u00a9 2025 All Rights Reserved\r\nA remake that feels like a vital renewal, Bugonia updates Jang Joon-hwans Save the Green Planet!the 2003 South Kor\u2026 [+6643 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "ANI",
            "title": "Indian pharma sector needs price hikes, site and IP transfers to tackle US tariff uncertainty: Report",
            "description": "The report further noted that companies remain hopeful yet cautious around new growth avenues and product launches, which could help them offset the erosion in high-value launches",
            "url": "https://www.thehindubusinessline.com/economy/indian-pharma-sector-needs-price-hikes-site-and-ip-transfers-to-tackle-us-tariff-uncertainty-report/article70028449.ece",
            "urlToImage": "https://bl-i.thgim.com/public/incoming/6577zy/article70028462.ece/alternates/LANDSCAPE_1200/IMG_BL_-_27_09_2018_-_87_2_1_OMCE9LVM.jpg",
            "publishedAt": "2025-09-09T04:08:56Z",
            "content": "The Indian pharmaceutical industry requires price increases, site and intellectual property (IP) transfers to deal with the prevailing uncertainty in the sector amid US tariffs, according to a report\u2026 [+2507 chars]"
        },
        {
            "source": {
                "id": "the-times-of-india",
                "name": "The Times of India"
            },
            "author": "ANI",
            "title": "Indian pharma sector needs price hikes, site and IP transfers to tackle US tariff uncertainty: Report",
            "description": "A Systematix Research report indicates the Indian pharmaceutical industry is navigating uncertainty due to US tariffs, necessitating price increases, site transfers, and IP transfers. While raw material prices stabilize and companies explore new growth avenue\u2026",
            "url": "https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-pharma-sector-needs-price-hikes-site-and-ip-transfers-to-tackle-us-tariff-uncertainty-report/articleshow/123777518.cms",
            "urlToImage": "https://img.etimg.com/thumb/msid-123777527,width-1200,height-630,imgsize-14706,overlay-economictimes/articleshow.jpg",
            "publishedAt": "2025-09-09T03:51:49Z",
            "content": "The Indian pharmaceutical industry requires price increases, site and intellectual property (IP) transfers to deal with the prevailing uncertainty in the sector amid US tariffs, according to a report\u2026 [+2537 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Livemint"
            },
            "author": "list.metadata.agency",
            "title": "Indian pharma sector needs price hikes, site and IP transfers to tackle US tariff uncertainty: Report",
            "description": "The Indian pharmaceutical industry requires price increases, site and intellectual property (IP) transfers to deal with the prevailing uncertainty in the sector amid US tariffs, according to a report by Systematix Research",
            "url": "https://www.livemint.com/companies/news/indian-pharma-sector-needs-price-hikes-site-and-ip-transfers-to-tackle-us-tariff-uncertainty-report-11757388205384.html",
            "urlToImage": "https://www.livemint.com/lm-img/img/2024/12/06/1600x900/company_1_1733464951182_1733464958176.png",
            "publishedAt": "2025-09-09T03:23:24Z",
            "content": "New Delhi [India], September 9 (ANI): The Indian pharmaceutical industry requires price increases, site and intellectual property (IP) transfers to deal with the prevailing uncertainty in the sector \u2026 [+2539 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "KS Badri Narayanan",
            "title": "Infosys, Sun Pharma, Strides Pharma, Railtel, Vedanta, Tata Communications, Ujjivan SFB, IRB Infra to seek market attention on Tuesday (September 9, 2025)",
            "description": "Infosys board to meet on September 11 for equity shares buyback proposal; Sun Pharma discontinues Vecuronium Bromide Injection.",
            "url": "https://www.thehindubusinessline.com/markets/infosys-sun-pharma-strides-pharma-railtel-vedanta-tata-communications-ujjivan-sfb-irb-infra-to-seek-market-attention-on-tuesday-september-9-2025/article70028317.ece",
            "urlToImage": "https://bl-i.thgim.com/public/incoming/yj48qf/article70021800.ece/alternates/LANDSCAPE_1200/PO_Candle_chart.jpg",
            "publishedAt": "2025-09-09T02:37:30Z",
            "content": "Infosys on Monday said its board will meet on September 11 to consider a proposal for buyback of equity shares.\u00a0In 2022, the company had bought back shares worth 9,300 crore via an open market transa\u2026 [+3845 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "Team BL, KS Badri Narayanan",
            "title": "Share Market Highlights: Sensex rises 314 pts, Nifty tops 24,850; Infosys jumps 5% on buyback buzz",
            "description": "Sensex, Nifty updates on 9 Sept 2025: The Sensex gained 314 points to close at 81,101 and the Nifty ended 95 points higher at 24,869 on Tuesday, supported by IT stocks and hopes of a U.S. Fed rate cut. Infosys surged over 5% after announcing a board meet to c\u2026",
            "url": "https://www.thehindubusinessline.com/markets/stock-market-highlights-9-september-2025/article70026610.ece",
            "urlToImage": "https://bl-i.thgim.com/public/incoming/8bfcpv/article70021800.ece/alternates/LANDSCAPE_1200/PO_Candle_chart.jpg",
            "publishedAt": "2025-09-09T01:28:26Z",
            "content": "<li></li>\r\nSeptember 9, 2025 15:39CLOSING BELL: Sensex settled 314.02 pts or 0.39% higher at 81,101.32, and Nifty 50 ended with 95.45 pts or 0.39% gains at 24,868.60\r\n<li></li>\r\nSeptember 9, 2025 15:\u2026 [+36523 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Yuan Sun, Xiaoyang Shu, Lu Chen, Weijuan Shang, Yumin Zhang, Gengfu Xiao, Leike Zhang",
            "title": "Discovery and mechanistic insights of dibenzoylmethane as a broad spectrum inhibitor of coronavirus",
            "description": "Author summary In this study, we investigated the potential of dibenzoylmethane (DBM), a natural compound, as a therapeutic agent against human coronaviruses (HCoVs), including HCoV-OC43 and HCoV-229E, as well as more recent SARS-CoV-2 variants. Our findings \u2026",
            "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1013492",
            "urlToImage": "https://journals.plos.org/plospathogens/article/figure/image?id=10.1371/journal.ppat.1013492.g006&size=inline",
            "publishedAt": "2025-09-08T14:00:00Z",
            "content": "Abstract\r\nCoronavirus, a large family of positive-sense RNA viruses, are responsible for both mild and severe respiratory illnesses, ranging from the common cold to life-threatening conditions. Despi\u2026 [+76374 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Kffhealthnews.org"
            },
            "author": null,
            "title": "Monday, September 8, 2025",
            "description": null,
            "url": "https://kffhealthnews.org/morning-briefing/monday-september-8-2025/",
            "urlToImage": null,
            "publishedAt": "2025-09-08T12:46:37Z",
            "content": "Walgreens Private Equity Deal May Mean Closures, Threaten Patient Access\r\nAs part of the deal, Walgreens will be split into five privately owned companies, but experts warn that private equity takeov\u2026 [+7837 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Livemint"
            },
            "author": "Priyanka Sharma",
            "title": "Now Sun Pharma, Lupin work on anti-obesity pill to cut costs, address jab aversion",
            "description": "Sun Pharma and Lupin pursue regulatory approval for oral weight-loss drugs, potentially reshaping treatment access.",
            "url": "https://www.livemint.com/companies/now-sun-pharma-lupin-work-on-anti-obesity-pill-to-cut-costs-address-jab-aversion-11757239385114.html",
            "urlToImage": "https://www.livemint.com/lm-img/img/2025/09/07/1600x900/SUN-PHARM-RESULTS--0_1757255629292_1757255644553.JPG",
            "publishedAt": "2025-09-08T00:30:12Z",
            "content": "New Delhi: In a move to address India's obesity crisis, two major pharmaceutical companiesSun Pharma Laboratories Ltd and Lupin Ltdare working to create an affordable anti-obesity pill, according to \u2026 [+4565 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Lesswrong.com"
            },
            "author": "Elo",
            "title": "Medical decision making",
            "description": "Published on September 7, 2025 8:13 AM GMTLesswrong Sydney runs a local dojo once a month to talk about rationality topics. \u00a0This month our topic was \"medical decision making\". \u00a0This is our notes for considerations on how to make decisions. \u00a0Please feel free \u2026",
            "url": "https://www.lesswrong.com/posts/rR4n7iqfRdxMYbdMs/medical-decision-making",
            "urlToImage": "https://res.cloudinary.com/lesswrong-2-0/image/upload/v1654295382/new_mississippi_river_fjdmww.jpg",
            "publishedAt": "2025-09-07T08:13:21Z",
            "content": "Lesswrong Sydney runs a local dojo once a month to talk about rationality topics. \u00a0This month our topic was \"medical decision making\". \u00a0This is our notes for considerations on how to make decisions. \u2026 [+4509 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Tim.blog"
            },
            "author": "Tim Ferriss",
            "title": "The Tim Ferriss Show Transcripts: Dr. Dominic D\u2019Agostino \u2014 All Things Ketones, How to Protect the Brain and Boost Cognition, Sardine Fasting, Diet Rules, Revisiting Metformin and Melatonin, and More (#825)",
            "description": "Please enjoy this transcript of my interview with Dr. Dominic D\u2019Agostino (@DominicDAgosti2), a tenured associate professor in the Department of Molecular Pharmacology and Physiology at the University of South Florida Morsani College of Medicine and a Visiting\u2026",
            "url": "https://tim.blog/2025/09/05/https-tim-blog-2025-09-03-dr-dominic-dagostino-all-things-ketones-transcript/",
            "urlToImage": "https://tim.blog/wp-content/uploads/2025/09/Dominic-DAgostino-scaled.jpg",
            "publishedAt": "2025-09-05T20:58:59Z",
            "content": "Please enjoy this transcript of my interview with Dr. Dominic D\u2019Agostino(@DominicDAgosti2), a tenured associate professor in the Department of Molecular Pharmacology and Physiology at the University \u2026 [+99033 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "ETFE & ECTFE Coatings Company Evaluation Report 2025 | Orion Industries, Curtiss-Wright, and Aalberts Surface Technologies Lead the Market",
            "description": "Explore the comprehensive ETFE & ECTFE Coatings Companies Quadrant analysis, revealing key market players, technological advancements, and industry trends. The analysis evaluates 132 companies, highlighting the Top 11 as quadrant leaders. These high-performan\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/09/05/3145387/28124/en/ETFE-ECTFE-Coatings-Company-Evaluation-Report-2025-Orion-Industries-Curtiss-Wright-and-Aalberts-Surface-Technologies-Lead-the-Market.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2025-09-05T15:28:00Z",
            "content": "Dublin, Sept. 05, 2025 (GLOBE NEWSWIRE) -- The \"ETFE &amp; ECTFE Coatings - Company Evaluation Report, 2025\" has been added to ResearchAndMarkets.com's offering.\r\nThe ETFE &amp; ECTFE Coatings Compan\u2026 [+7385 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Jonah N. Cullen, Jakub Cieslak, Jessica L. Petersen, Rebecca R. Bellone, Carrie J. Finno, Ted S. Kalbfleisch, Kirstine Calloe, Stefano Capomaccio, Katia Cappelli, Stephen J. Coleman, Ottmar Distl, Sian A. Durward-Akhurst, Elena Giulotto, Natasha A. Hamilton, Emmeline W. Hill, Lisa M. Katz, Dan A. Klaerke, Gabriella Lindgren, David E. MacHugh, Mariusz Mackowski, James N. MacLeod, Julia Metzger, Barbara A. Murphy, Ludovic Orlando, Terje Raudsepp, Maurizio Silvestrelli, Eric Strand, Teruaki Tozaki, Dagmar S. Trachsel, Laura S. Valderrama Figueroa, Brandon D. Velie, Claire M. Wade, Bianca Waud, James R. Mickelson, Molly E. McCue",
            "title": "Charting the equine miRNA landscape: An integrated pipeline and browser for annotating, quantifying, and visualizing expression",
            "description": "Author summary MicroRNAs (miRNAs) play a critical role in gene regulation, influencing many biological processes including development, metabolism, and disease. Despite their importance, miRNA research in non-model species like the horse has remained limited.\u2026",
            "url": "https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1011835",
            "urlToImage": "https://journals.plos.org/plosgenetics/article/figure/image?id=10.1371/journal.pgen.1011835.g011&size=inline",
            "publishedAt": "2025-09-05T14:00:00Z",
            "content": "Abstract\r\nMicroRNAs (miRNAs) are essential regulators of gene expression, yet few comprehensive databases exist for miRNA expression in non-model species, limiting our ability to characterize their r\u2026 [+90107 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Acetaminophen Market Trends and Forecasts, 2023-2024 & 2025-2033 | Rising OTC Demand, Wider Access to Essential Medicines, and Growth in Combination Therapies Drive Expansion",
            "description": "The global acetaminophen market is set to grow at a CAGR of 4.5% from 2025-2033, driven by continued demand for OTC pain relief and expanding access to essential medicines. Widely used across age groups for pain and fever, its usage in combination therapies a\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/09/05/3145154/28124/en/Acetaminophen-Market-Trends-and-Forecasts-2023-2024-2025-2033-Rising-OTC-Demand-Wider-Access-to-Essential-Medicines-and-Growth-in-Combination-Therapies-Drive-Expansion.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2025-09-05T09:53:00Z",
            "content": "Dublin, Sept. 05, 2025 (GLOBE NEWSWIRE) -- The \"Acetaminophen Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025\u2026 [+4561 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva",
            "description": "The Acute Respiratory Distress Syndrome (ARDS) market is projected to grow from $1.32 billion in 2024 to $2.53 billion by 2033, registering a CAGR of 7.51% from 2025 to 2033. Key factors driving this growth include the rise in chronic respiratory diseases, ad\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/09/04/3144742/28124/en/Acute-Respiratory-Distress-Syndrome-Market-Forecast-and-Company-Analysis-Report-2025-2033-Featuring-Ajanta-Akorn-Alembic-Cipla-Indoco-Remedies-J-J-Novartis-Ocular-Therapeutix-Sun-T.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2025-09-04T14:46:00Z",
            "content": "Dublin, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The \"Acute Respiratory Distress Syndrome Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033\" report has been added to ResearchAndM\u2026 [+7579 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Kffhealthnews.org"
            },
            "author": null,
            "title": "Thursday, September 4, 2025",
            "description": null,
            "url": "https://kffhealthnews.org/morning-briefing/thursday-september-4-2025/",
            "urlToImage": null,
            "publishedAt": "2025-09-04T12:52:25Z",
            "content": "Several Covid Vax Skeptics Might Join ACIP; RFK Jr. Testifies At Senate Today\r\nPolitico reports that it has seen an internal list that included the names of at least three people who have questioned \u2026 [+10574 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Raloxifene Hydrochloride Market Analysis Report 2025 | A $3.95 Billion Industry, Reaching $5.7 Billion by 2030 | Regional Healthcare and Supply Chain Trends",
            "description": "The raloxifene hydrochloride market offers opportunities through preventative health applications, particularly in women\u2019s health, with expanding relevance in cancer prevention and bone health. Market segmentation favors cost-effective generics and diverse re\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/09/04/3144396/28124/en/Raloxifene-Hydrochloride-Market-Analysis-Report-2025-A-3-95-Billion-Industry-Reaching-5-7-Billion-by-2030-Regional-Healthcare-and-Supply-Chain-Trends.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2025-09-04T11:36:00Z",
            "content": "Dublin, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The \"Raloxifene Hydrochloride Market by Indication (Breast Cancer Risk Reduction, Osteoporosis Prevention), Type (Branded, Generic), Distribution Channel, E\u2026 [+8906 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Globalsecurity.org"
            },
            "author": "John Pike",
            "title": "Grand Jury Indicts Three U.S. Citizens, 22 Chinese Nationals, Four Chinese Pharmaceutical Companies in International Drug Trafficking, Money Laundering Conspiracies",
            "description": "The Justice Department announced today that a federal grand jury in Dayton, Ohio, returned charges against dozens of defendants, including Chinese nationals and companies, in narcotics and money laundering conspiracies involving illegal cutting agents.",
            "url": "https://www.globalsecurity.org/security/library/news/2025/09/sec-250903-doj01.htm",
            "urlToImage": null,
            "publishedAt": "2025-09-04T09:25:24Z",
            "content": "Wednesday, September 3, 2025\r\nFor Immediate ReleaseOffice of Public Affairs\r\nThe Justice Department announced today that a federal grand jury in Dayton, Ohio, returned charges against dozens of defen\u2026 [+4810 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Mercola.com"
            },
            "author": "communities@mercola.com (Dr. Joseph Mercola)",
            "title": "Stopping Antidepressants Causes Withdrawal Symptoms, Study Shows",
            "description": "Antidepressants have a long, documented history of side effects while taking them. For example, they\u2019ve been shown to cause blurry vision, increased anxiety, constipation, sleep disturbances and loss of libido. As a result, around 56% of users are choosing to\u2026",
            "url": "https://articles.mercola.com/sites/articles/archive/2025/09/04/post-acute-withdrawal-syndrome.aspx",
            "urlToImage": "https://media.mercola.com/ImageServer/Public/2025/September/FB/post-acute-withdrawal-syndrome-fb.jpg",
            "publishedAt": "2025-09-04T00:00:00Z",
            "content": "Mercola proudly supports these charities and organizations. View All \r\nDisclaimer: The entire contents of this website are based upon the opinions of Dr. Mercola, unless otherwise noted. Individual a\u2026 [+1007 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Royal Society of Chemistry"
            },
            "author": "Phuong Vu Luu, Quoc-Dung Tran Huynh, Ngoc-Thac Pham, Huong-Giang Le, Lo-Yun Chen, Cuong-Quoc Nguyen, Huong Lien Ton-Nu, Mei-Hsien Lee, Yu-Chia Chang, Jui-Hsin Su, Bo-Rong Peng, Kuei-Hung Lai",
            "title": "Bioassay-guided isolation of terpenoids from the soft coral Sclerophytum humesi and assessment of their antidiabetic and cytotoxic activities",
            "description": "RSC Adv., 2025, 15,31965-31980DOI: 10.1039/D5RA04971G, Paper Open Access &nbsp This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.Phuong Vu Luu, Quoc-Dung Tran Huynh, Ngoc-Thac Pham, Huong-Giang Le, Lo-Yun Chen, C\u2026",
            "url": "https://pubs.rsc.org/en/content/articlelanding/2025/ra/d5ra04971g",
            "urlToImage": "https://pubs.rsc.org/en/Content/Image/GA/D5RA04971G",
            "publishedAt": "2025-09-03T23:00:00Z",
            "content": "* \r\n Corresponding authors\r\na\r\n Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei 110301, Taiwan\r\nE-mail:kueihunglai@tmu.edu.tw, pengpojung@gmail.com\r\nb\r\n In\u2026 [+1236 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Moneycontrol"
            },
            "author": "Moneycontrol News",
            "title": "New GST rates: Here's what will get cheaper; see full list of items",
            "description": "New GST rates: Here's what will get cheaper; see full list of itemsmoneycontrol.com",
            "url": "https://www.moneycontrol.com/news/business/new-gst-rates-here-s-what-will-get-cheaper-see-full-list-of-items-13518159.html",
            "urlToImage": "https://images.moneycontrol.com/static-mcnews/2025/09/20250903120115_Finance-Minister-Nirmala-Sitharaman.png",
            "publishedAt": "2025-09-03T17:17:16Z",
            "content": "In a major tax reform, the GST Council on Wednesday agreed to cut GST slabs to two: 5% and 18%. The existing 12% and 28% will be eliminated, effectively reducing the prices of several items.\r\nIn a la\u2026 [+133815 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Tim.blog"
            },
            "author": "Tim Ferriss",
            "title": "Dr. Dominic D\u2019Agostino \u2014 All Things Ketones, How to Protect the Brain and Boost Cognition, Sardine Fasting, Diet Rules, Revisiting Metformin and Melatonin, and More (#825)",
            "description": "Interview with Dr. Dominic D\u2019Agostino on The Tim Ferriss Show podcast. \nThe post Dr. Dominic D\u2019Agostino \u2014 All Things Ketones, How to Protect the Brain and Boost Cognition, Sardine Fasting, Diet Rules, Revisiting Metformin and Melatonin, and More (#825) appear\u2026",
            "url": "https://tim.blog/2025/09/03/dr-dominic-dagostino-all-things-ketones/",
            "urlToImage": "https://tim.blog/wp-content/uploads/2025/09/Dominic-DAgostino-scaled.jpg",
            "publishedAt": "2025-09-03T15:10:04Z",
            "content": "Dr. Dominic DAgostino (@DominicDAgosti2) is a tenured associate professor in the Department of Molecular Pharmacology and Physiology at the University of South Florida Morsani College of Medicine and\u2026 [+24205 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Zhengguang Shi, Bingyao Li, Raluca Simina Bilti",
            "title": "Constraints to sustainable energy technology implementation: Insights from an emerging economy using ISM-MICMAC analysis",
            "description": "The growing environmental, economic, and social challenges have compelled governments and policymakers to incorporate sustainable energy technologies. However, the development of sustainable energy technologies is hindered by various barriers in emerging econ\u2026",
            "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0331334",
            "urlToImage": "https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0331334.g003&size=inline",
            "publishedAt": "2025-09-03T14:00:00Z",
            "content": "Abstract\r\nThe growing environmental, economic, and social challenges have compelled governments and policymakers to incorporate sustainable energy technologies. However, the development of sustainabl\u2026 [+52102 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Pazopanib Generics Market Analysis and Forecast 2025-2030: Regional Variances in Regulatory and Reimbursement Frameworks Demand Tailored Market Entry Strategies",
            "description": "Dublin, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The \"Pazopanib Generics Market by Application (Ovarian Cancer, Renal Cell Carcinoma, Soft Tissue Sarcoma), Dosage Form (Capsule, Injectable, Tablet), Route Of Administration, Distribution Channel, End User - Global F\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/09/03/3143349/28124/en/Pazopanib-Generics-Market-Analysis-and-Forecast-2025-2030-Regional-Variances-in-Regulatory-and-Reimbursement-Frameworks-Demand-Tailored-Market-Entry-Strategies.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2025-09-03T08:23:00Z",
            "content": "Dublin, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The \"Pazopanib Generics Market by Application (Ovarian Cancer, Renal Cell Carcinoma, Soft Tissue Sarcoma), Dosage Form (Capsule, Injectable, Tablet), Route \u2026 [+6895 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Anastrozole APl Market Analysis and Growth Forecast Report 2025-2030 Featuring Profiles of Key Players and Innovations",
            "description": "The Anastrozole API market presents key opportunities through technological innovation, regulatory alignment, and strategic collaborations. Advanced manufacturing and green chemistry enhance efficiency and sustainability, while compliance with evolving regula\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/09/03/3143348/28124/en/Anastrozole-APl-Market-Analysis-and-Growth-Forecast-Report-2025-2030-Featuring-Profiles-of-Key-Players-and-Innovations.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2025-09-03T08:20:00Z",
            "content": "Dublin, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The \"Anastrozole APl Market by Generic Status (Branded, Generic), Application (Breast Cancer Treatment, Gynecomastia), Distribution Channel, End User - Glob\u2026 [+8106 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Naturalnews.com"
            },
            "author": "Cassie B.",
            "title": "Vitamin D proven to slow aging in groundbreaking Harvard study",
            "description": "A Harvard study proves daily vitamin D slows cellular aging by preserving telomere length in adults over 50. Vitamin D reduces inflammation, a key driver of telomere shortening and chronic diseases linked to aging. Pharmaceutical companies ignore natural solu\u2026",
            "url": "https://www.naturalnews.com/2025-09-03-vitamin-d-slow-aging-study.html",
            "urlToImage": "https://www.naturalnews.com/wp-content/uploads/sites/91/2025/09/vitamin-D-capsules-2.jpeg",
            "publishedAt": "2025-09-03T06:00:00Z",
            "content": "<ul><li>A Harvard study proves daily vitamin D slows cellular aging by preserving telomere length in adults over 50.</li><li>Vitamin D reduces inflammation, a key driver of telomere shortening and ch\u2026 [+4030 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PR Newswire UK"
            },
            "author": null,
            "title": "Clostridioides difficile Infection Market Forecasts by DelveInsight Signal Groundbreaking Growth at a CAGR of 13.5% in the 7MM during the Forecast Period (2025-2034)",
            "description": "The Clostridioides difficile infection market is predicted to boost mainly owing to an increased aging population, increased focus on R&D on antimicrobial resistance solutions, ongoing public health initiatives, and approval/adoption of next-generation therap\u2026",
            "url": "https://www.prnewswire.co.uk/news-releases/clostridioides-difficile-infection-market-forecasts-by-delveinsight-signal-groundbreaking-growth-at-a-cagr-of-13-5-in-the-7mm-during-the-forecast-period-20252034-302543478.html",
            "urlToImage": "https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg?p=facebook",
            "publishedAt": "2025-09-02T21:31:00Z",
            "content": "The Clostridioides difficile infection market is predicted to boost mainly owing to an increased aging population, increased focus on R&amp;D on antimicrobial resistance solutions, ongoing public hea\u2026 [+24351 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Nayak Deeksha Dayanand, Vasudha Devi, Shama Prasada Kabbekodu, Arul Amuthan, Sathish Pai B, Rajasekhar Chinta",
            "title": "Phytochemical and pharmacoinformatics analysis of a traditional antipsoriatic oil formulation for its potential against proinflammatory cytokines TNF-\u03b1 and IL-17A",
            "description": "Psoriasis, a persistent inflammatory condition with a complex origin, lacks a definitive cure despite the availability of diverse treatments. Vetpalai thailam (VT), a Siddha formulation, is commonly used for addressing various skin ailments. Analysis via GC-M\u2026",
            "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0330939",
            "urlToImage": "https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0330939.g014&size=inline",
            "publishedAt": "2025-09-02T14:00:00Z",
            "content": "Citation: Dayanand ND, Devi V, Kabbekodu SP, Amuthan A, Pai B S, Chinta R (2025) Phytochemical and pharmacoinformatics analysis of a traditional antipsoriatic oil formulation for its potential agains\u2026 [+39338 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SNS Insider pvt ltd",
            "title": "Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 as Demand for Hormone Therapy Accelerates \u2013 SNS Insider",
            "description": "U.S. Leuprolide Acetate Market to Grow from USD 0.88 Billion in 2024 to USD 1.26 Billion by 2032, Driven by Rising Prostate Cancer Incidence and Expanding Adoption in Reproductive Health. U.S. Leuprolide Acetate Market to Grow from USD 0.88 Billion in 2024 to\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/09/02/3142444/0/en/Leuprolide-Acetate-Market-to-Reach-USD-4-43-Billion-by-2032-as-Demand-for-Hormone-Therapy-Accelerates-SNS-Insider.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/d6272c2e-d204-41b8-b545-a6e2e24f85c2",
            "publishedAt": "2025-09-02T10:30:00Z",
            "content": "Austin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Leuprolide Acetate Market Size &amp; Growth Analysis\r\nAccording to SNS Insider, the Leuprolide Acetate Market size was valued at USD 2.92 billion in 2024 an\u2026 [+10054 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Precedence Research",
            "title": "Acne Medicine Market Size Projected to Reach USD 23.33 Billion by 2034",
            "description": "The global acne medication market is valued at USD 14.86 billion in 2025 and is projected to grow to approximately USD 23.33 billion by 2034, registering a compound annual growth rate (CAGR) of 5.14% over the forecast period. The global acne medication market\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/09/01/3142183/0/en/Acne-Medicine-Market-Size-Projected-to-Reach-USD-23-33-Billion-by-2034.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/01eb1f79-0c67-420b-b423-376619f975cd",
            "publishedAt": "2025-09-01T14:00:00Z",
            "content": "Ottawa, Sept. 01, 2025 (GLOBE NEWSWIRE) -- The global\u00a0acne medication market size to rise from USD 14.13 billion in 2024 and is expected to reach around USD 23.33 billion by 2034, growing at a compou\u2026 [+14732 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "New York Post"
            },
            "author": "Miska Salemann",
            "title": "Are parasites wrecking your gut? The best parasite cleanses and how they work, per experts",
            "description": "Parasites crashing the party? Here's the best way to kick them out.",
            "url": "https://nypost.com/health/best-parasite-cleanses-per-experts/",
            "urlToImage": "https://nypost.com/wp-content/uploads/sites/2/2025/08/parasite-cleanse.jpg?quality=75&strip=all&w=1024",
            "publishedAt": "2025-09-01T13:00:00Z",
            "content": "New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase.\r\nCant figure out why you\u2019ve been feeling off?\r\nIf you\u2019ve been d\u2026 [+22597 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "Anupama Ghosh",
            "title": "Sensex tops 80,200, Nifty nears 24,565 as auto stocks lead midday gains",
            "description": "Sensex at 80,224 and Nifty at 24,565 as auto stocks surge. Strong GDP and PMI data lift sentiment, but FII selling, tariffs, and volatility keep traders cautious.",
            "url": "https://www.thehindubusinessline.com/markets/stock-markets/sensex-tops-80200-nifty-nears-24565-as-auto-stocks-lead-midday-gains/article69999084.ece",
            "urlToImage": "https://bl-i.thgim.com/public/incoming/qq9ln/article69988172.ece/alternates/LANDSCAPE_1200/PO04_Candle_Chart.jpg",
            "publishedAt": "2025-09-01T07:42:25Z",
            "content": "Markets maintained their upward momentum at midday on Monday, with the Sensex rising 414.77 points or 0.52 per cent to 80,224.42 and the Nifty 50 gaining 137.65 points or 0.56 per cent to 24,564.50 a\u2026 [+2548 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "Anupama Ghosh",
            "title": "Markets open higher as strong GDP data offsets trade war concerns",
            "description": "The Nifty 50 index opened at 24,432.70, up from its previous close of 24,426.85, and was trading at 24,530.30; Sensex opened at 79,828.99, compared to its previous close of 79,809.65, and rose to 80,174.22",
            "url": "https://www.thehindubusinessline.com/markets/markets-open-higher-as-strong-gdp-data-offsets-trade-war-concerns/article69998670.ece",
            "urlToImage": "https://bl-i.thgim.com/public/incoming/1qe01a/article69998682.ece/alternates/LANDSCAPE_1200/IMG_PO31_Chart_1_2_1_TAER61OV.jpg",
            "publishedAt": "2025-09-01T04:39:08Z",
            "content": "Markets opened on a positive note Monday morning, with the Nifty 50 starting at 24,432.70 from its previous close of 24,426.85 and trading at 24,530.30, up 103.45 points or 0.42 per cent, at 9.40 am.\u2026 [+3938 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Mercola.com"
            },
            "author": "communities@mercola.com (Dr. Joseph Mercola)",
            "title": "Weekly Health Quiz: AI Tools for Healthcare, Omega-3 Research, and Benefits of Infrared Saunas",
            "description": "1 What is a major benefit of AI tools like MAI-DxO for your healthcare?\r\n\n<ul>\n<li>Three times higher accuracy with 50% cost reduction</li>\n<li>Two times higher accuracy with 80% cost reduction</li>\n<li>Over four times higher accuracy with 70% cost reduction\n\u2026",
            "url": "https://articles.mercola.com/sites/articles/archive/2025/09/01/weekly-health-quiz-38.aspx",
            "urlToImage": "https://media.mercola.com/ImageServer/Public/2024/December/FB/weekly-health-quiz-fb.jpg",
            "publishedAt": "2025-09-01T00:00:00Z",
            "content": "Mercola proudly supports these charities and organizations. View All \r\nDisclaimer: The entire contents of this website are based upon the opinions of Dr. Mercola, unless otherwise noted. Individual a\u2026 [+1007 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "The Colorado Sun"
            },
            "author": "Mike Littwin",
            "title": "RFK Jr. predicted a \u201cdystopian nightmare.\u201d And now, thanks to him, it has arrived",
            "description": "Kennedy has basically eviscerated the CDC. And now, after limiting COVID vaccines, you can bet childhood vaccines are next.",
            "url": "http://coloradosun.com/2025/08/31/cdc-kennedy-health-opinion-littwin/",
            "urlToImage": "https://i0.wp.com/newspack-coloradosun.s3.amazonaws.com/wp-content/uploads/2022/07/Littwin-Opinion-Featured-Image.png?fit=1200%2C628&quality=80&ssl=1",
            "publishedAt": "2025-08-31T18:37:27Z",
            "content": "The assault on medical science, and a few other sciences as well, has hit a fever pitch in Donald Trumps America.\r\nAnd good luck finding a vaccine for that.\r\nAnyone who was paying the least bit of at\u2026 [+6356 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Hilda Bastian",
            "title": "More New Covid Vaccine Candidates, Trials, and Preclinical Studies (NextGen Update 32)",
            "description": "This month, there was unexpected Project NextGen news: A new phase 1 clinical trial started, for an exosome vaccine. There was also\u2026\nThe post More New Covid Vaccine Candidates, Trials, and Preclinical Studies (NextGen Update 32) appeared first on Absolutely M\u2026",
            "url": "https://absolutelymaybe.plos.org/2025/08/31/more-new-covid-vaccine-candidates-trials-and-preclinical-studies-nextgen-update-32/",
            "urlToImage": "https://absolutelymaybe.plos.org/wp-content/uploads/sites/8/2023/07/Emergency-vax-scaled.jpg",
            "publishedAt": "2025-08-31T08:34:28Z",
            "content": "This month, there was unexpected Project NextGen news: A new phase 1 clinical trial started, for an exosome vaccine. There was also another phase 4 trial report for CanSino\u2019s inhaled viral vector vac\u2026 [+39961 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "7NEWS.com.au"
            },
            "author": "Demi Huang",
            "title": "Family reveals accused cop killer Dezi Freeman\u2019s long-standing desire to \u2018torture\u2019 police in chilling text",
            "description": "Family reveals accused cop killer Dezi Freeman\u2019s long-standing desire to \u2018torture\u2019 police in chilling text7news.com.au",
            "url": "https://7news.com.au/news/family-reveals-accused-cop-killer-dezi-freemans-long-standing-desire-to-torture-police-in-chilling-text-c-19862290",
            "urlToImage": "https://images.7news.com.au/publication/C-19862290/8266ea69524d1e2b35166f0044395ffd325c4afd-16x9-x0y0w1280h720.png?imwidth=1200",
            "publishedAt": "2025-08-31T05:18:07Z",
            "content": "Accused police killer Dezi Freeman has once told his family he would torture a cop for days and video it in a chilling text message.\r\nThe self-proclaimed sovereign citizen, 56, allegedly shot dead tw\u2026 [+3253 chars]"
        },
        {
            "source": {
                "id": "the-times-of-india",
                "name": "The Times of India"
            },
            "author": "Reuters",
            "title": "Are you taking a common heart attack pill? It might not help you, study says",
            "description": "Two large trials offer conflicting evidence on the benefits of beta-blockers for heart attack patients with normal heart function. While one study showed no effect, another indicated a reduced risk of adverse cardiovascular events. Both trials agreed that bet\u2026",
            "url": "https://economictimes.indiatimes.com/news/international/world-news/are-you-taking-a-common-heart-attack-pill-it-might-not-help-you-study-says/articleshow/123599804.cms",
            "urlToImage": "https://img.etimg.com/thumb/msid-123599814,width-1200,height-630,imgsize-85200,overlay-economictimes/articleshow.jpg",
            "publishedAt": "2025-08-30T09:37:31Z",
            "content": "A decades-old pill remains helpful for heart attack patients even with modern treatments that can prevent lasting damage to heart muscle, two large trials have shown.Still unclear is whether all pati\u2026 [+3731 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SNS Insider pvt ltd",
            "title": "Antiemetics Drugs Market to Hit USD 11.69 Billion by 2032, Driven by Rising Cancer Cases, Chemotherapy Demand, and Breakthrough Formulations \u2013 SNS Insider",
            "description": "SNS Insider Projects U.S. Antiemetics Drugs Market to Surpass USD 3.56 Billion by 2032, Capturing Strong Share Amid Growth in Oncology Care and Gastrointestinal Treatments. SNS Insider Projects U.S. Antiemetics Drugs Market to Surpass USD 3.56 Billion by 2032\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/08/29/3141515/0/en/Antiemetics-Drugs-Market-to-Hit-USD-11-69-Billion-by-2032-Driven-by-Rising-Cancer-Cases-Chemotherapy-Demand-and-Breakthrough-Formulations-SNS-Insider.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/d6272c2e-d204-41b8-b545-a6e2e24f85c2",
            "publishedAt": "2025-08-29T13:30:00Z",
            "content": "Austin, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Antiemetics Drugs Market Size &amp; Growth Analysis\r\nAccording to SNS Insider, the global Antiemetics Drugs Market was valued at USD 6.73 billion in 2023 and\u2026 [+10025 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "KuicK Research",
            "title": "Controlled Release Drug Delivery Market Size FDA Approved Drugs Clinical Trials Companies Report 2030",
            "description": "Global Controlled Release Drug Delivery Market Size Estimated to Surpass US$ 90 Billion By 2030 Says Kuick Research Global Controlled Release Drug Delivery Market Size Estimated to Surpass US$ 90 Billion By 2030 Says Kuick Research",
            "url": "https://www.globenewswire.com/news-release/2025/08/29/3141289/0/en/Controlled-Release-Drug-Delivery-Market-Size-FDA-Approved-Drugs-Clinical-Trials-Companies-Report-2030.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/4b0593d4-0134-4313-866b-b56a11c71af7",
            "publishedAt": "2025-08-29T06:40:00Z",
            "content": "Delhi, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Global Controlled Release Drug Delivery Market, Drug Dosage, Price, Sales and Clinical Trials Insight 2030 Report Finding and Highlights:\r\n<ul><li>Research Me\u2026 [+5709 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Naturalnews.com"
            },
            "author": "Olivia Cook",
            "title": "FDA recalls ice cream in 16 states over undeclared nuts after a packaging mix-up",
            "description": "Blue Bell is recalling half-gallon cartons of Moo-llennium Crunch Ice Cream mistakenly packaged in Chocolate Chip Cookie Dough cartons. The affected products, marked with lid code 061027524, contain undeclared almonds, pecans and walnuts. For people with nut \u2026",
            "url": "https://www.naturalnews.com/2025-08-29-fda-recalls-ice-cream-in-16-states.html",
            "urlToImage": "https://www.naturalnews.com/wp-content/uploads/sites/91/2025/08/Cute-Toddler-Girl-Eating-Ice-Cream.jpg",
            "publishedAt": "2025-08-29T06:00:00Z",
            "content": "<ul><li>Blue Bell is recalling half-gallon cartons of Moo-llennium Crunch Ice Cream mistakenly packaged in Chocolate Chip Cookie Dough cartons. The affected products, marked with lid code 061027524, \u2026 [+6615 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Corneal Ulcer Market Analysis and Forecasts 2023-2025 & 2025-2035 | Surging Demand for Advanced Therapies Amid Rising Infection Rates, Innovative Drug Delivery Solutions Enhance Treatment Adherence",
            "description": "The global corneal ulcer treatment market is expanding rapidly, driven by the rising prevalence of corneal infections, improvements in pharmacological and regenerative therapies, and growing awareness about the condition. Corneal ulcers, caused by bacterial, \u2026",
            "url": "https://www.globenewswire.com/news-release/2025/08/28/3140592/28124/en/Corneal-Ulcer-Market-Analysis-and-Forecasts-2023-2025-2025-2035-Surging-Demand-for-Advanced-Therapies-Amid-Rising-Infection-Rates-Innovative-Drug-Delivery-Solutions-Enhance-Treatme.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2025-08-28T09:24:00Z",
            "content": "Dublin, Aug. 28, 2025 (GLOBE NEWSWIRE) -- The \"Corneal Ulcer Market - A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035\" report has been added to Resea\u2026 [+7398 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Asimov.press"
            },
            "author": "Calum Drysdale",
            "title": "What We Find in the Sewers",
            "description": "Our ancestors once spread their excess effluent on their fields; now we mine it for vital molecules.",
            "url": "https://www.asimov.press/p/sewers",
            "urlToImage": "https://substackcdn.com/image/fetch/$s_!mJzl!,w_1200,h_600,c_fill,f_jpg,q_auto:good,fl_progressive:steep,g_auto/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fce3c8597-dd7a-433f-92a2-80023d3da72d_2000x1260.jpeg",
            "publishedAt": "2025-08-27T13:50:59Z",
            "content": "This article concludes Issue 07. See you next month for the launch of Issue 08!\r\nThe sewer is the conscience of the city. Everything there converges and confronts everything else.\r\n Victor Hugo, Les \u2026 [+40838 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SNS Insider pvt ltd",
            "title": "Hyperpigmentation Treatment Market Size to Hit USD 2.36 Billion by 2032, Fueled by Growing Demand for Advanced Dermatological Therapies and Aesthetic Procedures \u2013 SNS Insider",
            "description": "U.S. Hyperpigmentation Treatment Market Projected to Surpass USD 0.79 Billion by 2032, Driven by Strong Consumer Demand and Cutting-Edge Dermatology Innovations. U.S. Hyperpigmentation Treatment Market Projected to Surpass USD 0.79 Billion by 2032, Driven by \u2026",
            "url": "https://www.globenewswire.com/news-release/2025/08/27/3140119/0/en/Hyperpigmentation-Treatment-Market-Size-to-Hit-USD-2-36-Billion-by-2032-Fueled-by-Growing-Demand-for-Advanced-Dermatological-Therapies-and-Aesthetic-Procedures-SNS-Insider.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/d6272c2e-d204-41b8-b545-a6e2e24f85c2",
            "publishedAt": "2025-08-27T13:30:00Z",
            "content": "Austin, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Hyperpigmentation Treatment Market Size &amp; Growth Analysis\r\nAccording to SNS Insider, the global hyperpigmentation treatment market was valued at USD 1.34\u2026 [+8648 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Chronic Inducible Urticaria (CIndU) Market Research Report 2025-2035 | Competitive Analysis of AstraZeneca, Celldex Therapeutics, J&J, Merck, Novartis, Pfizer, Regeneron Pharma, Sanofi, Sun Pharma",
            "description": "The global chronic inducible urticaria (CIndU) market is experiencing significant transformation due to rising prevalence, advancements in diagnostics, and targeted immunotherapies. Affecting 0.1% to 3% of the population, CIndU is linked to conditions like al\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/08/27/3139790/28124/en/Chronic-Inducible-Urticaria-CIndU-Market-Research-Report-2025-2035-Competitive-Analysis-of-AstraZeneca-Celldex-Therapeutics-J-J-Merck-Novartis-Pfizer-Regeneron-Pharma-Sanofi-Sun-Ph.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2025-08-27T08:50:00Z",
            "content": "Dublin, Aug. 27, 2025 (GLOBE NEWSWIRE) -- The \"Chronic Inducible Urticaria Market - A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035\" report has been \u2026 [+9114 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Tardive Dyskinesia Market Research 2025-2035 | Expansion Fueled by Precision Medicine, Real-World Evidence, and Wearable Technologies Driving Patient-Centered Care",
            "description": "The global tardive dyskinesia (TD) treatment market is experiencing significant growth due to the increased prevalence of psychiatric disorders, heightened clinical awareness, and advancements in pharmacological and digital therapies. Key drivers include the \u2026",
            "url": "https://www.globenewswire.com/news-release/2025/08/27/3139780/28124/en/Tardive-Dyskinesia-Market-Research-2025-2035-Expansion-Fueled-by-Precision-Medicine-Real-World-Evidence-and-Wearable-Technologies-Driving-Patient-Centered-Care.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2025-08-27T08:36:00Z",
            "content": "Dublin, Aug. 27, 2025 (GLOBE NEWSWIRE) -- The \"Tardive Dyskinesia Market - A Global and Regional Analysis: Focus on Drug Class, Route of Administration, and Region - Analysis and Forecast, 2025-2035\"\u2026 [+6865 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Still's Disease Market Research Report 2025-2035 | Pharma Leaders, Biotech Innovators, and Research Collaborations Drive Novel Cytokine Inhibitors, Combination Therapies, and Companion Diagnostics",
            "description": "The global Still's disease treatment market is poised for significant growth driven by advancements in biologic therapies, increasing awareness, and early diagnosis enabled by improving healthcare infrastructure, particularly in developed regions. The rise of\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/08/27/3139778/28124/en/Still-s-Disease-Market-Research-Report-2025-2035-Pharma-Leaders-Biotech-Innovators-and-Research-Collaborations-Drive-Novel-Cytokine-Inhibitors-Combination-Therapies-and-Companion-D.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2025-08-27T08:32:00Z",
            "content": "Dublin, Aug. 27, 2025 (GLOBE NEWSWIRE) -- The \"Still's Disease Market - A Global and Regional Analysis: Focus on Route of Administration and Region - Analysis and Forecast, 2025-2035\" report has been\u2026 [+7960 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Bezawit kassa, Asiya Mohammed, Gizachew Tadesse Wassie",
            "title": "Parents\u2019 acceptance of human papilloma virus vaccination for their daughters in adet town, North Gojjam zone, Northwest Ethiopia: A mixed method study",
            "description": "Human papilloma virus vaccination is an effective way to reduce cervical cancer. Although the health of adolescents is the priority goal across the globe, including Ethiopia, parent s\u2019 acceptance of Human papilloma virus vaccination for their daughters become\u2026",
            "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0330911",
            "urlToImage": "https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0330911.g001&size=inline",
            "publishedAt": "2025-08-26T14:00:00Z",
            "content": "Abstract\r\nHuman papilloma virus vaccination is an effective way to reduce cervical cancer. Although the health of adolescents is the priority goal across the globe, including Ethiopia, parent s accep\u2026 [+50599 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Tech Xplore"
            },
            "author": "David Chandler",
            "title": "Can large language models figure out the real world? New metric measures AI's predictive power",
            "description": "In the 17th century, German astronomer Johannes Kepler figured out the laws of motion that made it possible to accurately predict where our solar system's planets would appear in the sky as they orbit the sun. But it wasn't until decades later, when Isaac New\u2026",
            "url": "https://techxplore.com/news/2025-08-large-language-figure-real-world.html",
            "urlToImage": "https://scx2.b-cdn.net/gfx/news/hires/2025/planetary-orbits.jpg",
            "publishedAt": "2025-08-26T13:56:05Z",
            "content": "In the 17th century, German astronomer Johannes Kepler figured out the laws of motion that made it possible to accurately predict where our solar system's planets would appear in the sky as they orbi\u2026 [+8389 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Controlled Release Drug Delivery Market and Clinical Pipeline Report: A $90 Billion Opportunity in Controlled Release Drug Delivery by 2030",
            "description": "The controlled release drug delivery market offers substantial growth opportunities driven by increasing demand for improved therapeutic regimens for chronic conditions like cancer and neurological disorders. Innovations by companies like AbbVie and AstraZene\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/08/26/3139019/28124/en/Controlled-Release-Drug-Delivery-Market-and-Clinical-Pipeline-Report-A-90-Billion-Opportunity-in-Controlled-Release-Drug-Delivery-by-2030.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2025-08-26T08:10:00Z",
            "content": "Dublin, Aug. 26, 2025 (GLOBE NEWSWIRE) -- The \"Global Controlled Release Drug Delivery Market, Drug Dosage, Price and Clinical Pipeline Insight 2030\" drug pipelines has been added to ResearchAndMarke\u2026 [+10949 chars]"
        },
        {
            "source": {
                "id": "the-times-of-india",
                "name": "The Times of India"
            },
            "author": "Riya Sharma",
            "title": "Sun Pharma shares slip 3% after BofA downgrade on premium valuations",
            "description": "Bank of America downgraded Sun Pharma stock to \u2018underperform\u2019 from \u2018neutral\u2019, citing risks to premium valuations and slower speciality execution. The brokerage cut its target price, flagging concerns over Ilumya\u2019s Medicare exposure, pricing pressures, and lim\u2026",
            "url": "https://economictimes.indiatimes.com/markets/stocks/news/sun-pharma-shares-slip-3-after-bofa-downgrade-on-premium-valuations/articleshow/123519218.cms",
            "urlToImage": "https://img.etimg.com/thumb/msid-123519205,width-1200,height-630,imgsize-67320,overlay-etmarkets/articleshow.jpg",
            "publishedAt": "2025-08-26T06:37:16Z",
            "content": "Shares of Sun Pharmaceutical fell as much as 2.8% on Tuesday to an intraday low of Rs 1,610 on the BSE after Bank of America Securities downgraded the stock to 'underperform' from 'neutral', citing r\u2026 [+2413 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "Team BL, KS Badri Narayanan",
            "title": "Share Market Highlights: US tariffs on Indian goods drag markets; Sensex, Nifty fall over 1%",
            "description": "Sensex, Nifty updates on 26 Aug 2025: Indian equity markets closed sharply lower on Tuesday as global headwinds and fresh US trade measures rattled sentiment. The BSE Sensex fell 849 points, or 1.04%, to 80,786, while the NSE Nifty50 lost 256 points, or 1.02%\u2026",
            "url": "https://www.thehindubusinessline.com/markets/stock-market-highlights-26-aug-2025/article69975262.ece",
            "urlToImage": "https://bl-i.thgim.com/public/incoming/6fu9ux/article69954679.ece/alternates/LANDSCAPE_1200/PO09_Stockmarket_data.jpg",
            "publishedAt": "2025-08-26T01:31:46Z",
            "content": "<li></li>\r\nAugust 26, 2025 16:36Stock market live today: Aluminium extrusion sector seeks Govt support amid US tariffs, cheap imports\r\nUS Tariff Challenges: Aluminium extrusion sector seek policy sup\u2026 [+74836 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Forbes"
            },
            "author": "Forbes Asia Team, Forbes Staff, \n Forbes Asia Team, Forbes Staff\n https://www.forbes.com/sites/forbesasiateam/",
            "title": "Forbes Asia 100 To Watch 2025",
            "description": "Our fifth annual Forbes Asia 100 to Watch list provides a window into the vibrant world of startups and small companies in the Asia-Pacific region. Drawing nearly $3 billion in funding to date, these companies operate in fast-rising sectors such as biotechnol\u2026",
            "url": "https://www.forbes.com/sites/forbesasiateam/2025/08/25/forbes-asia-100-to-watch-2025/",
            "urlToImage": "https://imageio.forbes.com/specials-images/imageserve/68ac21f6d52d969bf5fcbae8/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds",
            "publishedAt": "2025-08-25T21:45:00Z",
            "content": "O\r\nur fifth annual Forbes Asia 100 to Watch list provides a window into the vibrant world of startups and small companies in the Asia-Pacific region. Its a constantly evolving ecosystem, which is inc\u2026 [+65829 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Mit.edu"
            },
            "author": "David Chandler | Laboratory for Information and Decision Systems",
            "title": "Can large language models figure out the real world?",
            "description": "A new approach assesses how deeply predictive AI systems understand their subject matter, and whether they can apply knowledge from one domain to a slightly different one.",
            "url": "https://news.mit.edu/2025/can-large-language-models-figure-out-real-world-0825",
            "urlToImage": "https://news.mit.edu/sites/default/files/images/202508/Foundation-models.jpg",
            "publishedAt": "2025-08-25T20:30:00Z",
            "content": "Back in the 17th century, German astronomer Johannes Kepler figured out the laws of motion that made it possible to accurately predict where our solar systems planets would appear in the sky as they \u2026 [+7587 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Boston Herald"
            },
            "author": "Tribune News Service",
            "title": "Do storms scare your dog? A new drug could help",
            "description": "Almost half of dogs fear loud noises, especially fireworks and thunder.",
            "url": "https://www.bostonherald.com/2025/08/25/drug-dogs-storm-scares/",
            "urlToImage": "https://www.bostonherald.com/wp-content/uploads/2025/08/202508180400MCT_____PHOTO____LIF-PETS-STORM-ANXIETY-PT_bbd476.jpg?w=1024&h=682",
            "publishedAt": "2025-08-25T17:33:31Z",
            "content": "By Lane DeGregory, Tampa Bay Times\r\nTAMPA, Fla. The first time Tammy freaked out, her human had no idea what was happening.\r\nIt was summer, two years ago, afternoon sun streaming through the windows \u2026 [+5339 chars]"
        },
        {
            "source": {
                "id": "fortune",
                "name": "Fortune"
            },
            "author": "Tom Murphy, The Associated Press",
            "title": "Your health insurance bill could jump 75% in 2026 if Congress fails to act, experts say: \u2018something we haven\u2019t seen in a very long time\u2019",
            "description": "Health insurance will grow more expensive in many areas in 2026, and coverage may shrink. That could leave patients paying more for doctor visits.",
            "url": "https://fortune.com/2025/08/25/how-much-health-insurance-bill-go-up-coverage-cost/",
            "urlToImage": "https://fortune.com/img-assets/wp-content/uploads/2025/08/GettyImages-1752039685.jpg?resize=1200,600",
            "publishedAt": "2025-08-25T16:31:11Z",
            "content": "Pricey prescriptions\u00a0and nagging medical costs are swamping some insurers and employers now. Patients may start paying for it next year.Health insurance will grow more expensive in many corners of th\u2026 [+4896 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PBS"
            },
            "author": "Tom Murphy, Associated Press",
            "title": "Health insurance prices are likely to rise next year, experts say",
            "description": "Price changes could be especially stark in individual coverage marketplaces, where insurers also are predicting the end of some government support that helps people buy coverage.",
            "url": "https://www.pbs.org/newshour/health/health-insurance-prices-are-likely-to-rise-next-year-experts-say",
            "urlToImage": "https://d3i6fh83elv35t.cloudfront.net/newshour/app/uploads/2014/12/187238643-1024x682.jpg",
            "publishedAt": "2025-08-25T14:45:18Z",
            "content": "Pricey prescriptions and nagging medical costs are swamping some insurers and employers now. Patients may start paying for it next year.\r\nHealth insurance will grow more expensive in many corners of \u2026 [+5444 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Livemint"
            },
            "author": "Jessica Jani",
            "title": "Mint Explainer | First Dr Reddy\u2019s, now Natco: Why Indian drugmakers are suing Novo Nordisk",
            "description": "As the patent for semaglutide nears its end, Novo Nordisk's dominance in the weight-loss market is being challenged. The lawsuits could pave the way for cheaper generics, catering to India's vast population battling obesity.&nbsp;",
            "url": "https://www.livemint.com/companies/dr-reddy-s-natco-indian-drugmakers-novo-nordisk-patent-lawsuits-weight-loss-drugs-wegovy-ozempic-generic-drugs-11756124743725.html",
            "urlToImage": "https://www.livemint.com/lm-img/img/2025/08/25/1600x900/INDIA-WEGOVY-6_1751614661405_1751614669024_1756126241653.jpg",
            "publishedAt": "2025-08-25T13:03:18Z",
            "content": "Two Indian drugmakers have filed lawsuits against Danish drugmaker Novo Nordisk over its blockbuster weight-loss drug semaglutide, which is set to lose its patent in India in March 2026. With just ab\u2026 [+4426 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "TribLIVE"
            },
            "author": "Associated Press",
            "title": "Expect health insurance prices to rise next year, brokers and experts say",
            "description": "Pricey prescriptions and nagging medical costs are swamping some insurers and employers now. Patients may start paying for it next year. Health insurance will grow more expensive in many corners of the market in 2026, and coverage may shrink. That could leave\u2026",
            "url": "https://triblive.com/news/world/expect-health-insurance-prices-to-rise-next-year-brokers-and-experts-say/",
            "urlToImage": "https://assets-varnish.triblive.com/2025/08/8806683_web1_AP25231729897362.jpg",
            "publishedAt": "2025-08-25T12:56:17Z",
            "content": "Pricey prescriptions and nagging medical costs are swamping some insurers and employers now. Patients may start paying for it next year.\r\nHealth insurance will grow more expensive in many corners of \u2026 [+4892 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "MarketsandMarkets Research Pvt. Ltd.",
            "title": "Global Suppositories Market to Surpass USD 2.05 Billion by 2030 | MarketsandMarkets\u2122",
            "description": "Rising demand for localized treatment options and innovation in pharmaceutical technologies are reshaping the suppositories market landscape Rising demand for localized treatment options and innovation in pharmaceutical technologies are reshaping the supposit\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/08/25/3138488/0/en/Global-Suppositories-Market-to-Surpass-USD-2-05-Billion-by-2030-MarketsandMarkets.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/afcc5182-4ae0-43a8-a965-4351d590b7ed",
            "publishedAt": "2025-08-25T12:45:00Z",
            "content": "Delray Beach, FL, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The global suppositories market, valued at US$1.56 billion in 2024, stood at US$1.63 billion in 2025 and is projected to advance at a resilient CAG\u2026 [+5101 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "The Denver Post"
            },
            "author": "The Associated Press",
            "title": "Expect health insurance prices to rise next year, brokers and experts say",
            "description": "Health insurance will grow more expensive in many corners of the market in 2026, and some coverage may shrink.",
            "url": "https://www.denverpost.com/2025/08/25/health-care-costs-2026/",
            "urlToImage": "https://www.denverpost.com/wp-content/uploads/2025/08/Health_Insurance-2026_Pain-Explainer_97362.jpg?w=1024&h=682",
            "publishedAt": "2025-08-25T11:39:32Z",
            "content": "By TOM MURPHY, Associated Press Health Writer\r\nPricey prescriptions and nagging medical costs are swamping some insurers and employers now. Patients may start paying for it next year.\r\nHealth insuran\u2026 [+5161 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Boston Herald"
            },
            "author": "Associated Press",
            "title": "Expect health insurance prices to rise next year, brokers and experts say",
            "description": "Health insurance will grow more expensive in many corners of the market in 2026, and some coverage may shrink.",
            "url": "https://www.bostonherald.com/2025/08/25/health-care-costs-2026/",
            "urlToImage": "https://www.bostonherald.com/wp-content/uploads/2025/08/Health_Insurance-2026_Pain-Explainer_97362.jpg?w=1024&h=682",
            "publishedAt": "2025-08-25T11:39:32Z",
            "content": "By TOM MURPHY, Associated Press Health Writer\r\nPricey prescriptions and nagging medical costs are swamping some insurers and employers now. Patients may start paying for it next year.\r\nHealth insuran\u2026 [+5161 chars]"
        },
        {
            "source": {
                "id": "abc-news",
                "name": "ABC News"
            },
            "author": "TOM MURPHY AP health writer",
            "title": "Expect health insurance prices to rise next year, brokers and experts say",
            "description": "Pricey prescriptions and nagging medical costs are swamping some insurers and employers, which means patients may start paying more next year",
            "url": "https://abcnews.go.com/Health/wireStory/expect-health-insurance-prices-rise-year-brokers-experts-124943259",
            "urlToImage": "https://i.abcnewsfe.com/a/c1baac84-b44b-4aaf-bd0e-ce2dba1d041e/wirestory_c4d865ec09c7088ecc6b55dc520f3566_16x9.jpg?w=1600",
            "publishedAt": "2025-08-25T07:58:26Z",
            "content": "Pricey prescriptions and nagging medical costs are swamping some insurers and employers now. Patients may start paying for it next year.\r\nHealth insurance will grow more expensive in many corners of \u2026 [+4904 chars]"
        },
        {
            "source": {
                "id": "abc-news",
                "name": "ABC News"
            },
            "author": "TOM MURPHY AP health writer",
            "title": "Expect health insurance prices to rise next year, brokers and experts say",
            "description": "Pricey prescriptions and nagging medical costs are swamping some insurers and employers, which means patients may start paying more next year",
            "url": "https://abcnews.go.com/Business/wireStory/expect-health-insurance-prices-rise-year-brokers-experts-124943260",
            "urlToImage": "https://i.abcnewsfe.com/a/c1baac84-b44b-4aaf-bd0e-ce2dba1d041e/wirestory_c4d865ec09c7088ecc6b55dc520f3566_16x9.jpg?w=1600",
            "publishedAt": "2025-08-25T05:42:28Z",
            "content": "Pricey prescriptions and nagging medical costs are swamping some insurers and employers now. Patients may start paying for it next year.\r\nHealth insurance will grow more expensive in many corners of \u2026 [+4904 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "seattlepi.com"
            },
            "author": "By TOM MURPHY, AP Health Writer",
            "title": "Expect health insurance prices to rise next year, brokers and experts say",
            "description": "Pricey prescriptions and nagging medical costs are swamping some insurers and employers, which means patients may start paying more next year. Health insurance will grow more expensive in many corners of the market in 2026, and some coverage may shrink. That \u2026",
            "url": "https://www.seattlepi.com/business/article/expect-health-insurance-prices-to-rise-next-year-21013832.php",
            "urlToImage": "https://s.hdnux.com/photos/01/54/27/52/28408470/6/rawImage.jpg",
            "publishedAt": "2025-08-25T05:23:19Z",
            "content": "Pages from the U.S. Affordable Care Act health insurance website healthcare.gov are seen on a computer screen in New York on Tuesday, Aug. 19, 2025.\r\nPatrick Sison/AP\r\nPricey prescriptions and naggin\u2026 [+5641 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Yahoo Entertainment"
            },
            "author": "South China Morning Post",
            "title": "Hong Kong tops the US as the go-to IPO venue for Chinese start-ups as funds return to Asia",
            "description": "In the first of a two-part series about Hong Kong's market for initial public offerings, Zhang Shidong and Ao Yulu report that more Chinese companies opted...",
            "url": "https://finance.yahoo.com/news/hong-kong-tops-us-ipo-093000615.html",
            "urlToImage": "https://s.yimg.com/ny/api/res/1.2/ZrkQUFc43TATdAGuUhY6UQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/south_china_morning_post_us_228/cd61cae82b568a5326ac1ee1d19c0f19",
            "publishedAt": "2025-08-23T09:30:00Z",
            "content": "In the first of a two-part series about Hong Kong's market for initial public offerings, Zhang Shidong and Ao Yulu report that more Chinese companies opted to list in Hong Kong in the first eight mon\u2026 [+12949 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Jiaqiang Sun, Anita Binti Rosli, Adrian Daud",
            "title": "Efficiency analysis of listed pharmaceutical companies in China: A method combining three-stage DEA with undesirable output, PCA, and tobit regression",
            "description": "The pharmaceutical industry plays a vital role in safeguarding public health and enhancing industrial competitiveness. However, pharmaceutical industry in China faces persistent challenges, including high pollution, insufficient innovation, and limited profit\u2026",
            "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0329767",
            "urlToImage": "https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0329767.g004&size=inline",
            "publishedAt": "2025-08-22T14:00:00Z",
            "content": "1 Introduction\r\nThe pharmaceutical industry is an integral component of the national economy and public health, playing a crucial role in the healthcare value chain. As the worlds second-largest heal\u2026 [+93278 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Observer Research Foundation"
            },
            "author": "Lakshmy Ramakrishnan",
            "title": "Tariffs and Health Security: The Future of US\u2013India Pharma Trade",
            "description": "Tariffs and Health Security: The Future of US\u2013India Pharma Tradeorfonline.org",
            "url": "https://www.orfonline.org/expert-speak/tariffs-and-health-security-the-future-of-us-india-pharma-trade",
            "urlToImage": "https://www.orfonline.org/public/uploads/posts/image/thumbnail/1755861442_img-tarrif-pharma.jpg",
            "publishedAt": "2025-08-22T12:17:12Z",
            "content": "Indian pharmaceutical firms are currently exempt from tariffs imposed by the United States (US), but this insulation may not last. Duties on Indian imports currently stand at 25 percent but may doubl\u2026 [+12250 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "National Institutes of Health"
            },
            "author": null,
            "title": "Insights from 100 Years of Research with Probiotic E. Coli",
            "description": "A century ago, Alfred Nissle discovered that intentional intake of particular strains of Escherichia coli could treat patients suffering from infectious diseases. Since then, one of these strains became the most frequently used probiotic E. coli in ...",
            "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC5063008/",
            "urlToImage": "https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0",
            "publishedAt": "2025-08-22T07:10:15Z",
            "content": "Abstract\r\nA century ago, Alfred Nissle discovered that intentional intake of particular strains of Escherichia coli could treat patients suffering from infectious diseases. Since then, one of these s\u2026 [+86804 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Livemint"
            },
            "author": "mint",
            "title": "Mint Explainer | What India Inc\u2019s Q1 results mean for market investors",
            "description": "Despite signs of recovery in certain segments, the Q1 earnings season has painted a bleak picture for many companies in India, with single-digit growth persisting. Here's a look at the winners and losers of the Q1 results season",
            "url": "https://www.livemint.com/companies/company-results/india-inc-q1-fy26-results-q1-fy26-earnings-season-corporate-earnings-india-2025-bse500-companies-11755773668389.html",
            "urlToImage": "https://www.livemint.com/lm-img/img/2025/08/21/1600x900/mkt_1739444446027_1755776553217.png",
            "publishedAt": "2025-08-22T01:30:02Z",
            "content": "The curtains have come down on the earnings season for the first quarter of this financial year. Continued weakness in consumer sentiment, global macroeconomic turbulence and operational headwinds ma\u2026 [+11378 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "DelveInsight Business Research LLP",
            "title": "Pneumococcal Infections Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight",
            "description": "The pneumococcal infection market is poised for steady growth, driven by a combination of high global disease burden, rising antimicrobial resistance, and expanded immunization initiatives. Analyst sentiment remains positive as widespread public health progra\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/08/21/3137384/0/en/Pneumococcal-Infections-Clinical-Trial-Analysis-Key-Insights-into-Rich-Pipeline-Featuring-15-Companies-and-20-Therapies-DelveInsight.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db",
            "publishedAt": "2025-08-21T17:00:00Z",
            "content": "New York, USA, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pneumococcal Infections Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 15+ Companies and 20+ Therapies | DelveInsight\r\nThe pneumoc\u2026 [+14802 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Soichiro Hirasawa, Kentaro Murakami, Masayuki Kano, Satoshi Endo, Takeshi Toyozumi, Yasunori Matsumoto, Ryota Otsuka, Nobufumi Sekino, Tadashi Shiraishi, Takahiro Ryuzaki, Kazuya Kinoshita, Takuma Sasaki, Hisahiro Matsubara",
            "title": "MSC and HUVEC co-cultured fillers overcome intractable fistula in a new mouse model",
            "description": "Anastomotic leakage can lead to intractable fistulae after gastrointestinal surgery in patients with severe comorbidities. In this study, we aimed to devise new intractable fistula mouse models and evaluate the utility of the fillers containing human mesenchy\u2026",
            "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0330478",
            "urlToImage": "https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0330478.g004&size=inline",
            "publishedAt": "2025-08-21T14:00:00Z",
            "content": "Abstract\r\nAnastomotic leakage can lead to intractable fistulae after gastrointestinal surgery in patients with severe comorbidities. In this study, we aimed to devise new intractable fistula mouse mo\u2026 [+32847 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SNS Insider pvt ltd",
            "title": "Dementia Treatment Market Size to Surpass USD 33.54 Billion by 2032, Fueled by Breakthrough Therapies and Growing Patient Awareness \u2013 SNS Insider",
            "description": "SNS Insider Highlights U.S. Dementia Treatment Market Growth, Valued at USD 5.35 Billion in 2023, Poised to Reach USD 10.50 Billion by 2032, Driven by Aging Population and Advancements in Precision Medicine. SNS Insider Highlights U.S. Dementia Treatment Mark\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/08/21/3137231/0/en/Dementia-Treatment-Market-Size-to-Surpass-USD-33-54-Billion-by-2032-Fueled-by-Breakthrough-Therapies-and-Growing-Patient-Awareness-SNS-Insider.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/d6272c2e-d204-41b8-b545-a6e2e24f85c2",
            "publishedAt": "2025-08-21T13:30:00Z",
            "content": "Austin, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Dementia Treatment Market Size &amp; Growth Outlook\r\nAccording to SNS Insider, the global Dementia Treatment Market was valued at USD 17.06 billion in 2023 a\u2026 [+8634 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Precision Medicine Market Report 2025: Detailed Revenue Forecasting to 2035 on a Global and Regional Scale, Segmented by Product, Application, Technology and End-User",
            "description": "The market offers significant opportunities driven by increasing demand for personalized therapies, especially in oncology and rare diseases. Targeted therapies are crucial, with growth propelled by advancements in genomic sequencing and AI analytics. However\u2026",
            "url": "https://www.globenewswire.com/news-release/2025/08/21/3136917/28124/en/Precision-Medicine-Market-Report-2025-Detailed-Revenue-Forecasting-to-2035-on-a-Global-and-Regional-Scale-Segmented-by-Product-Application-Technology-and-End-User.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2025-08-21T08:29:00Z",
            "content": "Dublin, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The \"Precision Medicine Market Report 2025-2035\" has been added to ResearchAndMarkets.com's offering.\r\nThe Precision Medicine Market is set to exceed a globa\u2026 [+14031 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Naturalnews.com"
            },
            "author": "Lance D Johnson",
            "title": "Diabetes prevention can begin with something as simple as a morning cup of GREEN TEA",
            "description": "Green tea\u2019s story is one of resilience, a plant that has thrived through dynasties and empires, from the hands of Chinese emperors to the laboratories of today\u2019s most curious scientists. Its leaves hold a cocktail of compounds so intricate, so finely tuned by\u2026",
            "url": "https://www.naturalnews.com/2025-08-21-diabetes-prevention-green-tea-in-morning.html",
            "urlToImage": "https://www.naturalnews.com/wp-content/uploads/sites/91/2025/08/Green-Tea-Cup.jpg",
            "publishedAt": "2025-08-21T06:00:00Z",
            "content": "Green teas story is one of resilience, a plant that has thrived through dynasties and empires, from the hands of Chinese emperors to the laboratories of todays most curious scientists. Its leaves hol\u2026 [+5865 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Yahoo Entertainment"
            },
            "author": "South China Morning Post",
            "title": "Hong Kong's Hang Seng Index rebounds on US-China trade talk optimism",
            "description": "Hong Kong stocks on Wednesday reversed course to snap a four-day losing streak, spurred by comments from China's foreign ministry that traders interpreted as...",
            "url": "https://finance.yahoo.com/news/hong-kongs-hang-seng-index-093000682.html",
            "urlToImage": "https://s.yimg.com/ny/api/res/1.2/EOYw6kuj2E_ikdBy6fLyXw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/south_china_morning_post_us_228/cc0c03b78310cdb826a213c56057529b",
            "publishedAt": "2025-08-20T09:30:00Z",
            "content": "Hong Kong stocks on Wednesday reversed course to snap a four-day losing streak, spurred by comments from China's foreign ministry that traders interpreted as a sign of potential progress in the US-Ch\u2026 [+3351 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "The Quietus"
            },
            "author": "Patrick Clarke",
            "title": "The Strange World Of\u2026 Joe McPhee",
            "description": "After providing Severance with the soundtrack to its \"defiant jazz\" scene, the endlessly explorative work of legendary multi-instrumentalist Joe McPhee is enjoying a moment of rare mainstream crossover. With a new taster compilation coming this autumn, Stewar\u2026",
            "url": "https://thequietus.com/interviews/strange-world-of/joe-mcphee-discography-best-album-strange-world-of/",
            "urlToImage": "https://thequietus.com/app/uploads/2025/08/front-cover-844x1024.jpg",
            "publishedAt": "2025-08-20T09:02:58Z",
            "content": "After providing Severance with the soundtrack to its \"defiant jazz\" scene, the endlessly explorative work of legendary multi-instrumentalist Joe McPhee is enjoying a moment of rare mainstream crossov\u2026 [+21215 chars]"
        },
        {
            "source": {
                "id": "abc-news-au",
                "name": "ABC News (AU)"
            },
            "author": "Stephanie Dalzell and Paige Cockburn",
            "title": "Australian-first psychedelic-assisted therapy trial shows improved quality of life",
            "description": "An Australian-first trial using psychedelic-assisted therapy for terminally ill patients is showing promising results.",
            "url": "https://www.abc.net.au/news/2025-08-20/psychdelics-treatment-terminally-ill-mental-health/105670652",
            "urlToImage": "https://live-production.wcms.abc-cdn.net.au/5a237e8b8381a1a5e48cfb2f69eeb917?impolicy=wcms_watermark_news&cropH=1687&cropW=3000&xPos=0&yPos=157&width=862&height=485&imformat=generic",
            "publishedAt": "2025-08-19T18:33:39Z",
            "content": "Michael Quinn's prostate cancer had spread throughout his body when he came across a newspaper call-out that would change the course of what remained of his life.\r\nThe newspaper was asking for people\u2026 [+8668 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Connor Frey",
            "title": "A real-world pharmacovigilance analysis of ALK inhibitor-associated pleural and pericardial effusion using the FDA Adverse Events Reporting System (FAERS) database from 2013 to 2024",
            "description": "Introduction The advent of anaplastic lymphoma kinase (ALK) inhibitors has revolutionized the treatment of ALK-rearranged malignancies, establishing these agents as vital components of precision oncology. Despite their proven efficacy in prolonging progressio\u2026",
            "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0330630",
            "urlToImage": "https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0330630.t001&size=inline",
            "publishedAt": "2025-08-19T14:00:00Z",
            "content": "Abstract\r\nIntroduction\r\nThe advent of anaplastic lymphoma kinase (ALK) inhibitors has revolutionized the treatment of ALK-rearranged malignancies, establishing these agents as vital components of pre\u2026 [+24903 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "TheJournal.ie"
            },
            "author": "Press Association",
            "title": "Se\u00e1n Gallagher says he will \u2018reflect\u2019 on claims of attack on presidential hopeful Gareth Sheridan",
            "description": "Gareth Sheridan took a number of shots at former presidential candidate Se\u00e1n Gallagher during a press conference last week.",
            "url": "https://www.thejournal.ie/sean-gallagher-gareth-sheridan-6793827-Aug2025/",
            "urlToImage": "https://img2.thejournal.ie/article/6793827/river/?height=400&version=6793848",
            "publishedAt": "2025-08-19T12:58:37Z",
            "content": "FORMER PRESIDENTIAL CANDIDATE Se\u00e1n Gallagher said he will reflect on comments made by businessman Gareth Sheridan, who claimed he has been the victim of a coordinated attack on his character.\r\nSherid\u2026 [+2799 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Independent.ie"
            },
            "author": "Cate McCurry",
            "title": "Former presidential candidate Sean Gallagher says he will \u2018reflect\u2019 on Gareth Sheridan comments",
            "description": "Former presidential candidate Sean Gallagher said he will \u201creflect\u201d on comments made by Gareth Sheridan, who claimed he has been the victim of a \u201cco-ordinated attack\u201d on his character.",
            "url": "https://www.independent.ie/irish-news/former-presidential-candidate-sean-gallagher-says-he-will-reflect-on-gareth-sheridan-comments/a1700371062.html",
            "urlToImage": "https://focus.independent.ie/thumbor/uJEHqDhWtXcFiXvOcbAuYVueQTQ=/629x460/smart/prod-mh-ireland/49fc2541-0653-4140-aa37-5897682ef243/183a0945-eb4a-48f5-826e-4f0f4c3c30cb/49fc2541-0653-4140-aa37-5897682ef243.jpg",
            "publishedAt": "2025-08-19T12:26:14Z",
            "content": "Former presidential candidate Sean Gallagher said he will reflect on comments made by Gareth Sheridan, who claimed he has been the victim of a co-ordinated attack on his character.Mr Sheridan, who la\u2026 [+2637 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "CMI MARKET RESEARCH PRIVATE LIMITED",
            "title": "[Latest] Global Burial Insurance Market Size/Share Worth USD 458 Billion by 2034 at a 5.94% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
            "description": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Burial Insurance Market size & share revenue was valued at approximately USD 309.8 Billion in 2024 and is expected to reach USD \u2026",
            "url": "https://www.globenewswire.com/news-release/2025/08/19/3135604/0/en/Latest-Global-Burial-Insurance-Market-Size-Share-Worth-USD-458-Billion-by-2034-at-a-5-94-CAGR-Custom-Market-Insights-Analysis-Outlook-Leaders-Report-Trends-Forecast-Segmentation-Gr.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/74609d89-5437-4826-b7b8-31238ea2e65c",
            "publishedAt": "2025-08-19T11:30:00Z",
            "content": "Austin, TX, USA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled Burial Insurance Market Size, Trends and Insights By Coverage (Level Death Benefit\u2026 [+25053 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "The BMJ"
            },
            "author": "Bi-Cheng Liu, Zuo-Lin Li, Ping Zhang, Ai-Min Zhong, Ya-Ling Bai, Yan Xu, Bi-Hu Gao, Yan-Lin Li, Yu Wang, Ling-Hui Zhou, Li Yao, Jun-Xia Wang, Rui Yan, Liang Wang, Bing Liao, De-Qiong Xie, Xiang-Ming Yi, Tian-Jun Guan, Cai-Li Wang, Gui-Sen Li, Fang-Qiong Li, Jiang-Hua Chen",
            "title": "Efficacy and safety of anrikefon in patients with pruritus undergoing haemodialysis: multicentre, double blind, randomised placebo controlled phase 3 trial",
            "description": "Objective To evaluate the efficacy and safety of anrikefon (formerly known as HSK21542), a novel selective peripherally restricted kappa opioid receptor agonist, in patients with chronic kidney disease associated pruritus.\n\nDesign Multicentre, double blind, r\u2026",
            "url": "https://www.bmj.com/content/390/bmj-2025-085208",
            "urlToImage": "https://www.bmj.com/sites/default/files/highwire/bmj/390/8469.cover-source.jpg",
            "publishedAt": "2025-08-19T09:16:18Z",
            "content": "<ol><li>Bi-Cheng Liu, professor1, </li><li>Zuo-Lin Li, consultant nephrologist1, </li><li>Ping Zhang, professor2, </li><li>Ai-Min Zhong, professor3, </li><li>Ya-Ling Bai, professor4, </li><li>Yan Xu,\u2026 [+15000 chars]"
        },
        {
            "source": {
                "id": "the-times-of-india",
                "name": "The Times of India"
            },
            "author": "ET Now",
            "title": "FMCG in a sweet spot after GST cuts and monsoon boost: Rajat Sharma",
            "description": "Markets are positive due to GST bonanza. Rajat Sharma of Sana Securities highlights FMCG's sweet spot, driven by revised tax rates and good monsoons. Pharma sector is also attractive due to lack of tariffs and India's strong position in generics supply to the\u2026",
            "url": "https://economictimes.indiatimes.com/markets/expert-view/fmcg-in-a-sweet-spot-after-gst-cuts-and-monsoon-boost-rajat-sharma/articleshow/123378150.cms",
            "urlToImage": "https://img.etimg.com/thumb/msid-123378151,width-1200,height-630,imgsize-23144,overlay-etmarkets/articleshow.jpg",
            "publishedAt": "2025-08-19T04:56:29Z",
            "content": "\"For disclosure, HUL and Asian Paints have been my top picks since the beginning of this year, and I have mentioned this on your channel before. The slowdown in consumption had been so severe that a \u2026 [+4569 chars]"
        },
        {
            "source": {
                "id": "the-times-of-india",
                "name": "The Times of India"
            },
            "author": "ETMarkets.com",
            "title": "Glenmark, Alembic and Sun Pharma shares in focus on product recalls after US FDA action",
            "description": "Shares of Glenmark, Alembic, and Sun Pharma will be in focus after the USFDA flagged recalls over manufacturing lapses. Glenmark is recalling Carvedilol and Theophylline tablets due to nitrosamine impurities and failed dissolution tests, while Alembic pulled \u2026",
            "url": "https://economictimes.indiatimes.com/markets/stocks/news/glenmark-alembic-and-sun-pharma-shares-in-focus-on-product-recalls-after-us-fda-action/articleshow/123377418.cms",
            "urlToImage": "https://img.etimg.com/thumb/msid-123377405,width-1200,height-630,imgsize-34012,overlay-etmarkets/articleshow.jpg",
            "publishedAt": "2025-08-19T04:04:53Z",
            "content": "Shares of Glenmark Pharmaceuticals, Alembic Pharmaceuticals, and Sun Pharmaceutical Industries will be in focus on Tuesday, August 19, after the US Food and Drug Administration (USFDA) reported that \u2026 [+1813 chars]"
        },
        {
            "source": {
                "id": "the-times-of-india",
                "name": "The Times of India"
            },
            "author": "PTI",
            "title": "Glenmark, Alembic Pharma, Sun Pharma recall products in US: USFDA",
            "description": "Glenmark, Alembic Pharmaceuticals, and Sun Pharma are recalling various products in the US due to manufacturing issues, according to the USFDA. Glenmark is recalling Carvedilol tablets due to nitrosamine impurity and Theophylline tablets for failed dissolutio\u2026",
            "url": "https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-alembic-pharma-sun-recall-products-in-us-usfda/articleshow/123365050.cms",
            "urlToImage": "https://img.etimg.com/thumb/msid-123365204,width-1200,height-630,imgsize-55644,overlay-economictimes/articleshow.jpg",
            "publishedAt": "2025-08-18T12:13:22Z",
            "content": "Drug makers Glenmark, Alembic Pharmaceuticals and Sun Pharma are recalling products in the US due to manufacturing issues, according to the US health regulator.Mumbai-based Glenmark is recalling two \u2026 [+1833 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "The Atlantic"
            },
            "author": "Dan Wang",
            "title": "While China Builds, America Litigates",
            "description": "As the Chinese economy surges forward, the U.S. has lost its capacity for physical improvement.",
            "url": "https://www.theatlantic.com/ideas/archive/2025/08/china-america-tariffs-trump-economy/683895/",
            "urlToImage": "https://cdn.theatlantic.com/thumbor/v1Hf_JNcqUUu1sSRRCVybd8G6gM=/0x126:5923x3211/1200x625/media/img/mt/2025/08/2025_08_14_China_Builds/original.jpg",
            "publishedAt": "2025-08-18T10:00:00Z",
            "content": "After Donald Trump announced ruinously high tariffs on China in the spring, a simple reminder of that country\u2019s growing technological power forced him to back down. Shortly after Trump\u2019s April 2 tari\u2026 [+14100 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "The Atlantic"
            },
            "author": "Dan Wang",
            "title": "A Nation of Lawyers Confronts China\u2019s Engineering State",
            "description": "As the Chinese economy surges forward, the U.S. has lost its capacity for physical improvement.",
            "url": "https://www.theatlantic.com/ideas/archive/2025/08/china-america-tariffs-trump-economy/683895/?utm_source=yahoo-news",
            "urlToImage": "https://s.yimg.com/ny/api/res/1.2/RzQ9EjymbtxUrPwiVHao8g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU7Y2Y9d2VicA--/https://media.zenfs.com/en/the_atlantic_news_articles_892/6c0636eac85c9d72d2d7a72040a9ea9d",
            "publishedAt": "2025-08-18T10:00:00Z",
            "content": "The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the best in culture. Sign up for it here.\r\nAfter Donald Trump ann\u2026 [+14168 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "Team BL, KS Badri Narayanan",
            "title": "Stock Market Live Updates 18 August 2025:",
            "description": "Stock Market Today | Share Market Live Updates - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 18th August 2025",
            "url": "https://www.thehindubusinessline.com/markets/share-market-nifty-sensex-live-updates-18th-august-2025/article69943510.ece",
            "urlToImage": "https://bl-i.thgim.com/public/incoming/svtl4/article69563843.ece/alternates/LANDSCAPE_1200/IMG_BL1404_Corp_Buzz1_2_1_23E86LN6.jpg",
            "publishedAt": "2025-08-18T00:59:45Z",
            "content": "stack of silver coins with trading chart in financial concepts and financial investment business stock growth\r\n | Photo Credit: \r\n Sakorn Sukkasemsakorn\r\nStock Market today | Share Market Live Update\u2026 [+2395 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Daily Signal"
            },
            "author": "Erick Erickson",
            "title": "Secret to Life Is a Community of Friends",
            "description": "A few weeks ago, I participated in a \u201cCare-a-Thon\u201d for the AFLAC Cancer and Blood Disorders Center of Children\u2019s Healthcare of Atlanta. For 25 years,... Read More\nThe post Secret to Life Is a Community of Friends appeared first on The Daily Signal.",
            "url": "https://www.dailysignal.com/2025/08/16/secret-to-life-is-a-community-of-friends/",
            "urlToImage": "https://www.dailysignal.com/wp-content/uploads/2025/08/20250815Cancer01.jpg",
            "publishedAt": "2025-08-16T19:00:00Z",
            "content": "A few weeks ago, I participated in a Care-a-Thon for the AFLAC Cancer and Blood Disorders Center of Childrens Healthcare of Atlanta. For 25 years, my flagship radio station, WSB Radio in Atlanta, has\u2026 [+3971 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "BusinessLine"
            },
            "author": "Gurumurthy K & BL Research Bureau",
            "title": "Tech Query: Reliance Industries, Hindustan Copper, Federal Bank, Sun Pharmaceutical Industries; what is the outlook & where are these stocks headed?",
            "description": "We zoom in on the prospects of Reliance Industries, as also the prospects of three other stocks \u2014 Hindustan Copper, Federal Bank and Sun Pharmaceuticals Industries",
            "url": "https://www.thehindubusinessline.com/portfolio/technical-analysis/tech-query-reliance-industries-hindustan-copper-federal-bank-sun-pharmaceutical-industries-what-is-the-outlook-where-are-these-stocks-headed/article69936414.ece",
            "urlToImage": "https://bl-i.thgim.com/public/incoming/4gwgbk/article67338112.ece/alternates/LANDSCAPE_1200/PO24_bull%201.jpg",
            "publishedAt": "2025-08-16T15:07:26Z",
            "content": "I have bought Reliance Industries shares at 1,450. Can I hold it for long term?\r\nBolbin George\r\nReliance Industries (1,373.80): The long-term outlook is bullish. But in the short-term, there is room \u2026 [+2937 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "ETF Daily News"
            },
            "author": "MarketBeat News",
            "title": "Comparing Epiroc AB (publ) (OTCMKTS:EPOKY) and Croda International (OTCMKTS:COIHD)",
            "description": "Epiroc AB (publ) (OTCMKTS:EPOKY \u2013 Get Free Report) and Croda International (OTCMKTS:COIHD \u2013 Get Free Report) are both industrials companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutio\u2026",
            "url": "https://www.etfdailynews.com/2025/08/15/comparing-epiroc-ab-publ-otcmktsepoky-and-croda-international-otcmktscoihd/",
            "urlToImage": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/croda-international-plc-logo-1200x675.png?v=20210827144350&w=240&h=240&zc=2",
            "publishedAt": "2025-08-15T06:46:55Z",
            "content": "Epiroc AB (publ) (OTCMKTS:EPOKY \u2013 Get Free Report) and Croda International (OTCMKTS:COIHD \u2013 Get Free Report) are both industrials companies, but which is the superior business? We will compare the tw\u2026 [+6948 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Naturalnews.com"
            },
            "author": "Finn Heartley",
            "title": "Sunlight-Activated Superfoods: How Turmeric, Berries, and Broccoli Sprouts Become \u00e2\u0080\u0098Medicine\u00e2\u0080\u0099 Under UV Light",
            "description": "Sunlight boosts superfood potency: Natural compounds like curcumin (turmeric), anthocyanins (berries), and sulforaphane (broccoli sprouts) enhance antioxidant, anti-inflammatory, and anti-cancer effects with sun exposure. UV/IR light stabilizes nutrients: Sun\u2026",
            "url": "https://www.naturalnews.com/2025-08-15-sunlight-activated-superfoods-become-medicine-under-uv-light.html",
            "urlToImage": "https://www.naturalnews.com/wp-content/uploads/sites/91/2025/08/2025-08-15-BBN-BREAKTHROUGHS.jpg",
            "publishedAt": "2025-08-15T06:00:00Z",
            "content": "<ul><li>Sunlight boosts superfood potency: Natural compounds like curcumin (turmeric), anthocyanins (berries), and sulforaphane (broccoli sprouts) enhance antioxidant, anti-inflammatory, and anti-can\u2026 [+5425 chars]"
        }
    ]
}